Botanical drug company Xantho Biotechnology has announced that its atopic dermatitis (AD) treatment, GM-XANTHO, has advanced to phase II of clinical trials. This comes after years of rigorous …
( read original story …)
The Taiwan NEWS
Botanical drug company Xantho Biotechnology has announced that its atopic dermatitis (AD) treatment, GM-XANTHO, has advanced to phase II of clinical trials. This comes after years of rigorous …
( read original story …)